对甲状旁腺素的细胞和体液反应的病理及治疗意义 - Suppr

Suppr

超能文献

Pathological and therapeutic implications of the cellular and humoral responses to parathyrin.

作者信息

Parsons J A, Meunier P, Podbesek R, Reeve J, Stevenson R W

出版信息

Biochem Soc Trans. 1981 Oct;9(5):383-6. doi: 10.1042/bst0090383.

DOI:10.1042/bst0090383

PMID:7026314

Abstract

摘要

相似文献

Pathological and therapeutic implications of the cellular and humoral responses to parathyrin.对甲状旁腺素的细胞和体液反应的病理及治疗意义

Biochem Soc Trans. 1981 Oct;9(5):383-6. doi: 10.1042/bst0090383.

Calcium-47 kinetic measurements of bone turnover compared to bone histomorphometry in osteoporosis: the influence of human parathyroid fragment (hPTH 1-34) therapy.

Metab Bone Dis Relat Res. 1981;3(1):23-30. doi: 10.1016/s0221-8747(81)80019-7.

Intestinal absorption of calcium in greyhounds: the response to intermittent and continuous administration of human synthetic parathyroid hormone fragment 1-34 (hPTH 1-34).灵缇犬肠道对钙的吸收：对间歇性和持续性给予人合成甲状旁腺激素片段1-34（hPTH 1-34）的反应。

Clin Sci (Lond). 1984 Dec;67(6):591-9. doi: 10.1042/cs0670591.

The action of parathyroid hormone on bone metabolism may be regulated by endogenously synthesized prostaglandin E2.

Adv Prostaglandin Thromboxane Leukot Res. 1989;19:435-8.

Periodic courses of human 1-34 parathyroid peptide alternating with calcitriol paradoxically reduce bone remodelling in spinal osteoporosis.人甲状旁腺激素1-34的周期性疗程与骨化三醇交替使用，出人意料地减少了脊柱骨质疏松症中的骨重塑。

Eur J Clin Invest. 1987 Oct;17(5):421-8. doi: 10.1111/j.1365-2362.1987.tb01137.x.

[Anabolic activity of parathyroid hormone: a new therapeutic perspective in primary osteoporosis].[甲状旁腺激素的合成代谢活性：原发性骨质疏松症的新治疗前景]

Ann Ital Med Int. 1987 Oct-Dec;2(4):321-6.

Extraction of parathyroid hormone and release of adenosine 3',5'-monophosphate by isolated perfused bones obtained from dogs with acute uremia.

Endocrinology. 1982 Nov;111(5):1678-82. doi: 10.1210/endo-111-5-1678.

Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D.通过用人甲状旁腺激素（1-34）和1,25-二羟基维生素D治疗恢复骨质疏松男性的脊柱骨

J Bone Miner Res. 1986 Aug;1(4):377-81. doi: 10.1002/jbmr.5650010411.

Treatment of osteoporosis in men.男性骨质疏松症的治疗

Calcif Tissue Int. 2004 Aug;75(2):114-9. doi: 10.1007/s00223-004-0288-5. Epub 2004 Jul 29.

[Recombinant human parathyroid hormone--new perspectives for anabolic therapy of osteoporosis].

Pol Arch Med Wewn. 2004 Oct;112(4):1249-54.

引用本文的文献

Parathyroid hormone concentration gradients across the human bone marrow.人骨髓中甲状旁腺激素浓度梯度

Calcif Tissue Int. 1983 Jul;35(4-5):591-5. doi: 10.1007/BF02405099.

Results of a stimulatory therapy of low bone metabolism in osteoporosis with (1-38)hPTH and diphosphonate EHDP. Protocol of study I, osteoporosis trial Hannover.使用（1-38）人甲状旁腺激素（hPTH）和双膦酸盐依替膦酸二钠（EHDP）对骨质疏松症低骨代谢进行刺激疗法的结果。研究I方案，汉诺威骨质疏松症试验

Klin Wochenschr. 1988 Oct 3;66(19):976-84. doi: 10.1007/BF01738113.

Osteoporosis: regulatory view.骨质疏松症：监管视角。

Public Health Rep. 1987 Jul-Aug;102(4 Suppl):136-9.

Increase of vertebral density by combination therapy with pulsatile 1-38hPTH and sequential addition of calcitonin nasal spray in osteoporotic patients.

Calcif Tissue Int. 1989 Mar;44(3):176-80. doi: 10.1007/BF02556561.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验